Importantly, one study reported that there is a significant reduction of both MT1 and MT2 receptors in amygdaloid nucleus and SN of PD patients (Adi et al., 2010), possibly implying the significance of MT receptor in PD progression. Here, MTNR1A is linked to Parkinson disease.